164 related articles for article (PubMed ID: 17007705)
1. Clinical features of prostate cancer before diagnosis: a population-based, case-control study.
Hamilton W; Sharp DJ; Peters TJ; Round AP
Br J Gen Pract; 2006 Oct; 56(531):756-62. PubMed ID: 17007705
[TBL] [Abstract][Full Text] [Related]
2. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.
Hamilton W; Peters TJ; Round A; Sharp D
Thorax; 2005 Dec; 60(12):1059-65. PubMed ID: 16227326
[TBL] [Abstract][Full Text] [Related]
3. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of primary brain tumours: a case-control study using electronic primary care records.
Hamilton W; Kernick D
Br J Gen Pract; 2007 Sep; 57(542):695-9. PubMed ID: 17761056
[TBL] [Abstract][Full Text] [Related]
5. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Hattangadi JA; Chen MH; D'Amico AV
BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of colorectal cancer before emergency presentation: a population-based case-control study.
Cleary J; Peters TJ; Sharp D; Hamilton W
Fam Pract; 2007 Feb; 24(1):3-6. PubMed ID: 17142248
[TBL] [Abstract][Full Text] [Related]
7. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
[TBL] [Abstract][Full Text] [Related]
8. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
9. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
Issa MM; Zasada W; Ward K; Hall JA; Petros JA; Ritenour CW; Goodman M; Kleinbaum D; Mandel J; Marshall FF
Cancer Detect Prev; 2006; 30(3):269-75. PubMed ID: 16844319
[TBL] [Abstract][Full Text] [Related]
10. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
11. Predictive properties of serum-prostate-specific antigen testing in a community-based setting.
Jacobsen SJ; Bergstralh EJ; Guess HA; Katusic SK; Klee GG; Oesterling JE; Lieber MM
Arch Intern Med; 1996 Nov; 156(21):2462-8. PubMed ID: 8944739
[TBL] [Abstract][Full Text] [Related]
12. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
[TBL] [Abstract][Full Text] [Related]
13. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
Lilja H; Ulmert D; Björk T; Becker C; Serio AM; Nilsson JA; Abrahamsson PA; Vickers AJ; Berglund G
J Clin Oncol; 2007 Feb; 25(4):431-6. PubMed ID: 17264339
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
15. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
16. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
[TBL] [Abstract][Full Text] [Related]
17. An abnormal digital rectal examination is an independent predictor of Gleason > or =7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 men.
Borden LS; Wright JL; Kim J; Latchamsetty K; Porter CR
BJU Int; 2007 Mar; 99(3):559-63. PubMed ID: 17155976
[TBL] [Abstract][Full Text] [Related]
18. Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptoms.
Sayre EC; Bunting PS; Kopec JA
Can J Urol; 2009 Feb; 16(1):4463-71. PubMed ID: 19222884
[TBL] [Abstract][Full Text] [Related]
19. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing prostate cancer - what GPs need to know.
Frydenberg M; Wijesinha S
Aust Fam Physician; 2007 May; 36(5):345-7. PubMed ID: 17492070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
